Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agents

Journal of Pediatrics

Volumn 144, Issue 6, 2004, Pages 736-740

  Mahachoklertwattana, Pat ^a   Vilaiyuk, Soamarat ^a   Hongeng, Suradej ^a   Okascharoen, Chusak ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

ACTH; Acute lymphoblastic leukemia; Adrenocorticotropin; ALL; HPA; Hypothalamic pituitary adrenal

Indexed keywords

ASPARAGINASE; CORTICOSTEROID; CORTICOTROPIN; CYTARABINE; CYTOTOXIC AGENT; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADRENAL DISEASE; ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; AGE DISTRIBUTION; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG FEVER; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; STRESS; TREATMENT OUTCOME;

EID: 3042830646     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(04)00233-1     Document Type: Article

References (28)

1. Graber A.L, Ney R.L, Nicholson W.E, Island N.P, Liddle G.W. Natural history of pituitary-adrenal-recovery following long-term suppression with corticosteroids. J Clin Endocrinol Metab. 25:1965;11-16
2. Keller-Wood M.E, Dallman M.F. Corticosteroid inhibition of ACTH secretion. Endocr Rev. 5:1984;1-24
3. Fraser C.G, Preuss F.R, Bigford W.D. Adrenal atrophy and irreversible shock associated with cortisone therapy. JAMA. 149:1952;1542-1543
4. Morris H.G, Jorgensen J.R. Recovery of endogenous pituitary-adrenal function in corticosteroid-treated children. J Pediatr. 79:1971;480-488
5. Hanzen C, Suter A, Lerch E, Urbinelli R, Schorno X.H, Briner V.A. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet. 355:2000;542-545
6. Ackerman G.L, Nolsn C.M. Adrenocortical responsiveness after alternate-day corticosteroid therapy. N Engl J Med. 337:1997;1285-1292
7. Fass B. Glucocorticoid therapy for nonendocrine disorders: withdrawal and "coverage." Pediatr Clin North Am. 66:1979;910-914
8. Zora J.A, Zimmerman D, Carey T.L, O'Connell E.J, Yunginger J.W. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol. 77:1986;9-13
9. Lamberts S.W.J, Bruining H.A, de Jong F.H. Corticosteroid therapy in severe illness. N Engl J Med. 278:1968;405-409
10. Rubnitz J.E, Pui C.H. Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia. Cancer Treat Rev. 29:2003;31-44
11. Side effects of steroids revisited. J Pediatr. 137:2000;3-4. Editorial
12. Dixon R.B, Christy N.P. On the various forms of corticosteroid withdrawal syndrome. Am J Med. 68:1980;224-230
13. Felner E.I, Thompson M.T, Ratliff A.F, White P.C, Dickson B.A. Time course of recovery of adrenal function in children treated for leukemia. J Pediatr. 137:2000;21-24
14. Kuperman H, Domiani D, Chrousos G.P, et al. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy. J Clin Endocrinol Metab. 86:2001;2993-2996
15. Soule S.G, Fahie-Wilson M, Tomlison S. Failure of the short ACTH test to unequivocally diagnose long-standing symptomatic secondary hypoadrenalism. Clin Endocrinol. 44:1996;137-140
16. Dullaart R.P.F, Pasterkamp S.H, Beentjes J.A.M, Sluiter W.J. Evaluation of adrenal function in patients with hypothalamic and pituitary disorders: comparison of serum cortisol, urinary free cortisol and the human-corticotropin releasing hormone test with the insulin tolerance test. Clin Endocrinol. 50:1999;465-471
17. Beishuizen A, Lijf J.H, Lekkerkerker J.F.F, Vermes I. The low dose (1 μg) ACTH stimulation test for assessment of the hypothalamo-pituitary-adrenal axis. Neth J Med. 56:2000;91-99
18. Dickstein G, Spigel D, Arad E, Shecher C. One microgram is the lowest ACTH dose to cause maximal cortisol response: there is no diurnal variation of cortisol response to submaximal ACTH stimulation. Eur J Endocrinol. 137:1997;172-175
19. Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, Stern N. Low-dose (1 μg) adrenocorticotropin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 μg) test. Clin Endocrinol. 52:2000;633-640
20. Pui C.H, Evans W.E. Acute lymphoblastic leukemia. N Engl J Med. 339:1998;605-615
21. Grinspoon S.K, Biller B.M.K. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab. 79:1994;923-931
22. Agwu J.C, Spoudeas H, Hindmarsh P.C, Pringle P.J, Brook C.G.D. Tests of adrenal insufficiency. Arch Dis Child. 80:1999;330-333
23. Cooper M.S, Stewart P.M. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 348:2003;727-734
24. Thaler L.M, Blevins L.S. The low dose (1-μg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab. 83:1998;2726-2729
25. Abdu T.A.M, Elhadd T.A, Neary R, Clayton R.N. Comparison of the low dose short synacthen test (1 μg), the conventional dose short synacthen test (250 μg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab. 84:1999;838-843
26. Weintrob N, Sprecher E, Josefsberg Z, et al. Standard and low-dose short adrenocortcotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies. J Clin Endocrinol Metab. 83:1998;88-92
27. Linder B.L, Esteban N.V, Yergey A.L, Winterer J.C, Loriaux D.L, Cassoria F. Cortisol production rate in childhood and adolescence. J Pediatr. 117:1990;892-896
28. Kerrigan J.R, Veldhuis J.D, Leyo S.A, Iranmanesh A, Rogol A.D. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab. 76:1993;1505-1510